Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2015 | Improving outcomes in elderly patients with cancer

Matti Aapro • 12 Jun 2015
EHA 2015
Hodgkin Lymphoma Multiple Myeloma Non-Hodgkin Lymphoma

Cancer is a prevalent disease in elderly patients. At the 20th Congress of the European Hematology Association (EHA), Matti Aapro, MD, of Clinique de Genolier, Genolier, Switzerland, discusses some of the challenges in geriatric oncology research and the development of effective therapies for this patient population.

More from Matti Aapro

5:06
Considerations for drug development in hematological oncology
Matti Aapro • 12 Jun 2015

Related Videos

3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals